Kiss Tímea

1.

Balatoni, I., Kiss, T., Balla, G., Papp, Á., Csernoch, L.: Assessment of the physical activity of children with asthma bronchiale.
Sports. 12 (4), 1-16, (article identifier: 114), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Orthopedics and Sports Medicine

Q1 Physical Therapy, Sports Therapy and Rehabilitation

2.

Kacsir, I., Sipos, A., Kiss, T., Major, E., Bajusz, N., Tóth, E., Buglyó, P., Somsák, L., Kardos, G., Bai, P., Bokor, É.: Half sandwich-type osmium, ruthenium, iridium and rhodium complexes with bidentate glycosyl heterocyclic ligands induce cytostasis in platinum-resistant ovarian cancer cells and bacteriostasis in Gram-positive multiresistant bacteria.
Front. Chem. 11, 1-18, (article identifier: 1086267), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Chemistry (miscellaneous)

3.

Szász, I., Kiss, T., Mokánszki, A., Koroknai, V., Deák, J., Patel, V., Jámbor, K., Ádány, R., Balázs, M.: Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays.
Mol. Cell. Probes. 67, 1-8, (article identifier: 101888), 2023.

doi DEA Scopus

Journal metrics:

Q3 Cell Biology

Q3 Molecular Biology

4.

Balatoni, I., Szépné Varga, H., Kiss, T., Adamu, U. G., Szulc, A. M., Csernoch, L.: The Importance of Physical Activity in Preventing Fatigue and Burnout in Healthcare Workers.
Healthcare (Switzerland) 11 (13), 1915, (article identifier: 1915), 2023.

doi DEA WoS Scopus

Journal metrics:

Q3 Health Informatics

Q3 Health Information Management

Q2 Health Policy

Q2 Leadership and Management

5.

Jámbor, K., Koroknai, V., Kiss, T., Szász, I., Pikó, P., Balázs, M.: Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma.
Pathol. Oncol. Res. 28, 1-12, (article identifier: 1610608), 2022.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Oncology

Q2 Pathology and Forensic Medicine

6.

Szász, I., Koroknai, V., Patel, V., Hajdú, T., Kiss, T., Ádány, R., Balázs, M.: Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines.
Biomedicines. 9 (2), 1-18, (article identifier: 96), 2021.

doi DEA Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

7.

Patel, V., Szász, I., Koroknai, V., Kiss, T., Balázs, M.: Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines.
Cancers (Basel). 13 (23), 1-22, (article identifier: 6058), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

8.

Kiss, T., Jámbor, K., Koroknai, V., Szász, I., Bárdos, H., Mokánszki, A., Ádány, R., Balázs, M.: Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Pathol. Oncol. Res. 27, 1-10, (article identifier: 581395), 2021.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Oncology

Q2 Pathology and Forensic Medicine

9.

Szász, I., Koroknai, V., Kiss, T., Vízkeleti, L., Ádány, R., Balázs, M.: Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells.
Melanoma Res. 29 (4), 390-400, 2019.

doi DEA

Journal metrics:

Q3 Cancer Research

Q1 Dermatology

Q2 Oncology

10.

Vízkeleti, L., Kiss, T., Koroknai, V., Ecsedi, S., Papp, O., Szász, I., Ádány, R., Balázs, M.: Altered integrin expression patterns revealed by microarray in human cutaneous melanoma.
Melanoma Res. 27 (3), 180-188, 2017.

DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

11.

Koroknai, V., Ecsedi, S., Vízkeleti, L., Kiss, T., Szász, I., Lukács, A., Papp, O., Ádány, R., Balázs, M.: Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.
Melanoma Res. 2, 100-107, 2016.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

12.

Kiss, T., Ecsedi, S., Vízkeleti, L., Koroknai, V., Emri, G., Kovács, N., Ádány, R., Balázs, M.: The role of osteopontin expression in melanoma progression.
Tumor Biol. 36 (10), 7841-7847, 2015.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Medicine (miscellaneous)

13.

Ecsedi, S., Hernandez, V. H., Lima, S. C., Vízkeleti, L., Tóth, R., Lázár, V., Koroknai, V., Kiss, T., Emri, G., Herceg, Z., Ádány, R., Balázs, M.: DNA methylation characteristics of primary melanomas with distinct biological behaviour.
PloS One. 9 (5), e96612, 2014.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

14.

Vízkeleti, L., Ecsedi, S., Rákosy, Z., Orosz, A., Lázár, V., Emri, G., Koroknai, V., Kiss, T., Ádány, R., Balázs, M.: The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
Tumor Biol. 33 (6), 2189-2199, 2012.

doi DEA

Journal metrics:

Q3 Cancer Research

Q1 Medicine (miscellaneous)

Publication list